Renal Transplantation Clinical Trials

175 clinical trials for Renal Transplantation across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• The Effect of Emotion-Focused Intervention on Emotion Regulation and Well-Being of Individuals With Transplantation — RECRUITING · NA
• Pilates Exercises on Balance, Fatigue and Quality of Life — RECRUITING · NA
• Effect of a Preoperative Sensory Modulation Room on Pain, Anxiety, and Sleep in Kidney Transplant Patients — RECRUITING · NA
• Comparison of the Analgesic Effects of TFPB in Renal Transplantation Surgery — RECRUITING · NA
• Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study — RECRUITING · PHASE1
• Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients — RECRUITING
• Evaluation of the Efficacy of Dd-cfDNA in Routine Patient Care in Kidney Transplant Recipients" — RECRUITING · NA
• Knowledge of Cardiovascular Risk Factors in Chronic Kidney Disease Patients — RECRUITING
• Muscle Oxygenation, Functional Capacity and Frailty in Kidney Transplant Recipients with and Without Inspiratory Muscle Weakness — RECRUITING
• Exercise Capacity in Kidney Transplant Recipients — RECRUITING
• Combined Kidney and Hematopoietic Stem Cell Transplantation for Tolerance Induction — RECRUITING · PHASE2
• A 12-month open-label, randomized, multicenter, sequential cohort, dose finding study to evaluate the efficacy, safety and tolerability of oral AEB071 versus Neoral® in combination with Certican®, Simulect® and corticosteroids in de novo adult renal transplant recipients — COMPLETED · PHASE2
• Study to compare a tacrolimus Hexal® based regimen versus a Prograf® based regimen in renal transplantation — TERMINATED · PHASE4
• A controlled randomized open-label multicentre study evaluatiing if early conversion to everolimus (Certican) from cyclosporine (Neoral) in de novo renal transplant receipients can improve long-term renal function and slow down the progression of chronic allograft nephropathy — COMPLETED · PHASE3
• To evaluate the impact of early vs delayed introduction of everolimus on wound healing in patients newly transplanted kidney — COMPLETED · PHASE3
• 6-month, open-label, randomized, multicenter, prospective, controlled study to evaluate the efficacy, safety and tolerability of Everolimus in de novo renal transplant recipients participating in the Eurotransplant senior program — COMPLETED · PHASE3
• A 24 months, multi-center, open-label, randomized, controlled trial to investigate efficacy, safety and evolution of cardiovascular parameters in de novo renal transplant recipients after early calcineurin inhibitor to everolimus conversion — COMPLETED · PHASE4
• Evaluation de la pharmacodynamie, de l’efficacité et de la tolérance de 2 doses de Simulect® (40 ou 80 mg) en association ou non à un inhibiteur de la calcineurine. — COMPLETED · PHASE2
• Study Evaluating Rapamune® Maintenance Regimen — OTHER · PHASE3
• Assessment of everolimus in addition to calcineurin inhibitors reduction in maintenance renal transplant recipients (ASCERTAIN) — COMPLETED · PHASE3
• A 24-month, multicenter, randomized, open label non inferiority study of efficay and safety comparing concentration- controlled Certican in two doses (1.5 and 3.0 mg/day starting doses) with reduced Neoral versus 1.44 Myfortic with standard dose Neoral in de-novo renal transplant recipients — COMPLETED · PHASE3
• Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation — OTHER · PHASE4
• Evaluating the safety and efficacy of mycophenolate mofetil, daclizumab and a single, initial week of corticosteroids in combination with tacrolimus or sirolimus with continued steroid as mainstay immunosuppression in comparison to current standard immunosuppression (mycophenolate mofetil, tacrolimus and continued corticosteroids) in renal transplantation. — TERMINATED · PHASE4
• Comparison Between Ultrasound Guided Quadratus Lumborum Block and Erector Spinae Plane Block as an Analgesic Modality in Renal Transplant Donors — ACTIVE_NOT_RECRUITING · NA
• Belatacept Early Steroid Withdrawal Trial — COMPLETED · PHASE4
• Study of the Impact of VEGF Polymorphism on the Development of Renal Carcinoma in Renal Transplant Patients — COMPLETED
• Quantify the Benefits of Biomarkers in Routine Patient Care in Kidney Transplant Recipients — COMPLETED · NA
• Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN) — COMPLETED · PHASE3
• A Study of TCD601 in de Novo Renal Transplant Recipients — COMPLETED · PHASE2
• AADAPT - Analysis of Advagraf Dose Adaptation Post Transplantation — COMPLETED · PHASE4
• A multi-centre, open, prospective, randomized, parallel-group, 24-month study to compare the outcome of receiving continued immunosuppression versus stopping immunosuppression at 6 months to safely prevent human leukocyte antigen (HLA) sensitization in patients with late renal graft failure — TERMINATED · PHASE4
• Tolerance by Engaging Antigen During Cellular Homeostasis — COMPLETED · PHASE1
• Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation — SUSPENDED · PHASE2
• Whole Body Vibration Versus Aerobic Training on Interleukin 6 and Endurance After Renal Transplantation — COMPLETED · NA
• Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine — COMPLETED · NA
• 3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation — COMPLETED · PHASE3
• Correction of Anaemia and Progression of Renal Failure on Transplanted Patients — COMPLETED · PHASE4
• Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria. — COMPLETED · PHASE4
• Mesenchymal Stromal Cells in Living Donor Kidney Transplantation — ACTIVE_NOT_RECRUITING · PHASE2
• Impact of the Use of Remote Monitoring in the Follow-up of the Renal Transplant Patient. — ACTIVE_NOT_RECRUITING · NA
• Optimal Dose of Anti-lymphocyte Globulin in Kidney Transplant Recipients With Low Immunological Risk — NOT_YET_RECRUITING · PHASE1
• A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®) — COMPLETED
• Efficiency of everolimus for the treatment of kidney transplanted patients presenting a missing self-induced NK-mediated rejection (STARR) — TERMINATED · PHASE4
• A 12-Month, Randomized, Controlled, Open-Label, Dose Escalation Study Evaluating Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of an Anti-CD2 Monoclonal Antibody, TCD601(siplizumab) Compared to Anti-Thymocyte Globulin (rATG), as Induction Therapy in de novo Renal Transplant Recipients — OTHER · PHASE2
• Flumazenil Antagonism of Remimazolam in Kidney Transplant Patients — OTHER · PHASE1
• Effect of Probiotics on Immunosuppressive-drug-associated Diarrhea Among Renal Transplant Recipients — NOT_YET_RECRUITING · PHASE1
• Dexmedetomidine and Kidney Transplantation — NOT_YET_RECRUITING · PHASE4
• Urinary Biomarkers in Paediatric Kidney Transplantation (pKTx) — COMPLETED
• Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation — COMPLETED · PHASE4
• Effects of Reflexology in Transplant Patients — COMPLETED · NA

Refine this search